LATEST
GTCR agreed to acquire CCC Intelligent SolutionsnewEQT agreed to acquire StockbridgenewProofpoint agreed to acquire VaronisnewPyrophyte Acquisition . II / SakuuMotown Acquisition agreed to acquire Penske Automotive GroupVivos Therapeutics / SOD SciencesAtlasClear Holdings agreed to acquire Ark Financial ServicesLaboratory of America Holdings / BioReference HealthMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire Rocscience
Open App
ClosedPublished 28 Apr 2026

Gilead Sciences, Inc. /
Arcellx, Inc.

Gilead completes purchase of Arcellx

Buy side: Gilead Sciences, Inc.
Buy sideGilead Sciences, Inc.
Target: Arcellx, Inc.
TargetArcellx, Inc.
Gilead Sciences, Inc. · 28 Apr 2026Source
See the source
Buy side: Gilead Sciences, Inc.
Buy sideGilead Sciences, Inc.
Target: Arcellx, Inc.
TargetArcellx, Inc.
01 / BuyerGilead Sciences, Inc.
02 / TargetArcellx, Inc.
Source for the buyer and target: Gilead Sciences, Inc.

For the buyer and target.

“Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of its previously announced acquisition of Arcellx, Inc. (Nasdaq: ACLX).”

Published 28 Apr 2026

Open the source
01

What happened

Gilead Sciences has finished its takeover of Arcellx, giving it full control of the investigational multiple myeloma cell therapy anito-cel. Arcellx holders received $115 per share in cash plus one contingent value right worth $5 per share, a deal valued at roughly $7.8 billion at closing. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Gilead Sciences, Inc.

Gilead completes purchase of Arcellx

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by Gilead Sciences, Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.